- Home
- CING vs WVVI Comparison
CING vs WVVI Comparison
Compare CING & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CING
- WVVI
- Stock Information
- Founded
- CING 2012
- WVVI 1983
- Country
- CING United States
- WVVI United States
- Employees
- CING N/A
- WVVI N/A
- Industry
- CING Biotechnology: Pharmaceutical Preparations
- WVVI Beverages (Production/Distribution)
- Sector
- CING Health Care
- WVVI Consumer Staples
- Exchange
- CING Nasdaq
- WVVI Nasdaq
- Market Cap
- CING 26.7M
- WVVI 28.2M
- IPO Year
- CING 2021
- WVVI N/A
- Fundamental
- Price
- CING $4.04
- WVVI $4.68
- Analyst Decision
- CING Strong Buy
- WVVI
- Analyst Count
- CING 4
- WVVI 0
- Target Price
- CING $30.67
- WVVI N/A
- AVG Volume (30 Days)
- CING 173.5K
- WVVI 2.0K
- Earning Date
- CING 08-26-2025
- WVVI 08-12-2025
- Dividend Yield
- CING N/A
- WVVI N/A
- EPS Growth
- CING N/A
- WVVI N/A
- EPS
- CING N/A
- WVVI N/A
- Revenue
- CING N/A
- WVVI $38,384,350.00
- Revenue This Year
- CING N/A
- WVVI N/A
- Revenue Next Year
- CING N/A
- WVVI N/A
- P/E Ratio
- CING N/A
- WVVI N/A
- Revenue Growth
- CING N/A
- WVVI N/A
- 52 Week Low
- CING $3.02
- WVVI $3.17
- 52 Week High
- CING $20.83
- WVVI $7.18
- Technical
- Relative Strength Index (RSI)
- CING 40.42
- WVVI 39.84
- Support Level
- CING $3.50
- WVVI $4.72
- Resistance Level
- CING $4.31
- WVVI $4.86
- Average True Range (ATR)
- CING 0.46
- WVVI 0.10
- MACD
- CING -0.15
- WVVI 0.02
- Stochastic Oscillator
- CING 24.11
- WVVI 20.59
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.